Simvastatin-loaded β-TCP drug delivery system induces bone formation and prevents rhabdomyolysis in OVX mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23184712.
- Also identified by DOI 10.1002/adhm.201200342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bone formation and regeneration is a prolonged process that requires a slow drug release system to assist in the long-term recovery. A drug-delivery system is developed that allows for the controlled release of simvastin, without exhibiting the side effects associated with high concentrations of simvastatin, and is still capable of inducing constant bone formation.
Medical subject headings
- Calcium Phosphates
- Delayed-Action Preparations
- Osteogenesis
- Rhabdomyolysis
- Simvastatin